Naveris: Funding, Investors & Team (Oct 2026)
Naveris is a biotechnology company based in Waltham, Massachusetts that specializes in providing highly sensitive blood tests for early cancer detection in asymptomatic individuals, monitoring treatment response in patients, and detecting cancer recurrence in remission patients. The company uses 3D biomimetic technology to replicate the complex characteristics of human tissues and tumors, allowing for more efficient establishment of patient tumors ex vivo. This technology facilitates innovative designs for oncology clinical trials and precision medicine, aiming to match the most suitable therapies with individual patients. Naveris was established in 2017.
Naveris has raised $50.9M across 2 funding rounds on record, the most recent an undisclosed round of $17.5M announced in Jul 2024.
That round is above the $8.4M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
Naveris Company Profile and Key Stats
Latest funding round on record: Jul 2024.
Naveris Funding Rounds
Naveris raised $33.4M in a Series A announced in Sep 2022.
1.8 years later, an undisclosed round of $17.5M was announced in Jul 2024.
Naveris Founders and Leadership Team
No contact details are on record for this team yet.
Naveris Funding Compared to Other Biotechnology Startups
Naveris' latest round of $17.5M is above the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Naveris in Biotechnology and Waltham
Companies Similar to Naveris
Prolific Machines is a biotech company located in San Francisco, California, that was established in 2020. It…
Altay Therapeutics is a biotech company focused on finding and discovering small molecule therapies for…
Kallyope, we believe that the gut is the gateway to our internal world. Containing millions of neurons, the…
Astrocyte Pharmaceuticals is a drug development company that helps in the recovery and well-being of brain…
Tiny Health offers a gut health test specifically designed for mothers and babies aged 0 to 3 years.…
Junevity is dedicated to using cutting-edge transcription factor medicines to combat age-related diseases.…
Arkea Bio creates technology aimed at reducing greenhouse gas (GHG) emissions in the agricultural sector.
Serán is a contract development and manufacturing organization providing a comprehensive suite of…
Precision’s goal is to provide breakthrough treatments for the one billion patients worldwide suffering from…
Enveda is a biotechnology company that utilizes AI-powered tools to explore and characterize molecules from…
Avery Therapeutics, Inc. is a company dedicated to developing tissue engineered therapeutics to treat…
Naveris Funding FAQs
What does Naveris do?
Naveris is a biotechnology company based in Waltham, Massachusetts that specializes in providing highly sensitive blood tests for early cancer detection in asymptomatic individuals, monitoring treatment response in patients, and detecting cancer recurrence in remission patients. The company uses 3D biomimetic technology to replicate the complex characteristics of human tissues and tumors, allowing for more efficient establishment of patient tumors ex vivo. This technology facilitates innovative designs for oncology clinical trials and precision medicine, aiming to match the most suitable therapies with individual patients. Naveris was established in 2017.
How much funding has Naveris raised?
Naveris has raised $50.9M across 2 rounds on record. The most recent is an undisclosed round of $17.5M announced in Jul 2024.
When did Naveris last raise funding?
Naveris' most recent funding round on record is an undisclosed round of $17.5M, announced in Jul 2024.
Who founded Naveris?
FundedIQ lists Philip Haydon (Founder) at Naveris.
Who is the CEO of Naveris?
Piyush Gupta is listed as CEO at Naveris.
Where is Naveris headquartered?
Naveris is based in Waltham, Massachusetts, United States.
How many employees does Naveris have?
Naveris is in the 11-50 employee band.
How does Naveris' funding compare to other Biotechnology startups?
Naveris' latest round of $17.5M is above the $8.4M median round size for Biotechnology companies on FundedIQ across 4,185 tracked companies over the last two years.
About FundedIQ's Naveris Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Naveris is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Startup funding intelligence on every funded startup: the round, the investors and the founders, as a file in your inbox or searchable in the app.
Radar from $49/mo · Pro from $149/mo. Card required, nothing charged until day 15, and we email you 3 days before that. Need something specific? Custom plans from $499/mo.